Key facts
- Chongqing Dilan Biotechnology’s last known valuation is $110.2M (Dec 2024).
- It has raised $12.4M; the latest was Early Stage VC ($12.4M) in Dec 2024.
- Notable investors include Chengding Chuangfu Investment.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Chongqing Dilan Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Chongqing Dilan Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Chongqing Dilan Biotechnology
Developer and provider of biotechnology research, development, and applications designed for health and wellness industries. The company provides innovative products and services in hygiene, healthcare, and cosmetics, enabling consumers with integrated, data-driven solutions for hair health and hair care.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Chongqing, China
- Founded
- 2023
- Ownership
- Privately Held (backing)
Chongqing Dilan Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Chongqing Dilan Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Chongqing Dilan Biotechnology in its N-PORT filings yet. We sweep new filings monthly.